Clonal Hematopoiesis: From Macrovascular to Microvascular Disease

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2023 Mar 23

PMID 36951063

Authors

Jesse Cochran

Kenneth Walsh

Affiliations

Soon will be listed here.

Citing Articles

Impact of age and sex on myelopoiesis and inflammation during myocardial infarction.

Kanuri B, Biswas P, Dahdah A, Murphy A, Nagareddy P J Mol Cell Cardiol. 2024; 187:80-89.

PMID: 38163742 PMC: 10922716. DOI: 10.1016/j.yjmcc.2023.11.011.

References

Dhingra R, Vasan R . Age as a risk factor. Med Clin North Am. 2012; 96(1):87-91. PMC: 3297980. DOI: 10.1016/j.mcna.2011.11.003. View

Cosgrove J, Hustin L, De Boer R, Perie L . Hematopoiesis in numbers. Trends Immunol. 2021; 42(12):1100-1112. DOI: 10.1016/j.it.2021.10.006. View

Yura Y, Miura-Yura E, Katanasaka Y, Min K, Chavkin N, Polizio A . The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Promotes Inflammation and Non-Ischemic Heart Failure in Mice. Circ Res. 2021; 129(6):684-698. PMC: 8409899. DOI: 10.1161/CIRCRESAHA.121.319314. View

Fuster J, MacLauchlan S, Zuriaga M, Polackal M, Ostriker A, Chakraborty R . Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017; 355(6327):842-847. PMC: 5542057. DOI: 10.1126/science.aag1381. View

Sagris M, Theofilis P, Antonopoulos A, Oikonomou E, Paschaliori C, Galiatsatos N . Inflammation in Coronary Microvascular Dysfunction. Int J Mol Sci. 2021; 22(24). PMC: 8703507. DOI: 10.3390/ijms222413471. View

Zekavat S, Viana-Huete V, Matesanz N, Doroodgar Jorshery S, Zuriaga M, Uddin M . mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nat Cardiovasc Res. 2023; 2:144-158. PMC: 10026701. DOI: 10.1038/s44161-022-00206-6. View

Choi B, Matsuo Y, Aoki T, Kwon T, Prasad A, Gulati R . Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler Thromb Vasc Biol. 2014; 34(11):2473-7. PMC: 4212523. DOI: 10.1161/ATVBAHA.114.304445. View

Taqueti V, Di Carli M . Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(21):2625-2641. PMC: 6296779. DOI: 10.1016/j.jacc.2018.09.042. View

Svensson E, Madar A, Campbell C, He Y, Sultan M, Healey M . TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial. JAMA Cardiol. 2022; 7(5):521-528. PMC: 8988022. DOI: 10.1001/jamacardio.2022.0386. View

10.

Young A, Wong T, Hughes A, Heath S, Ley T, Link D . Quantifying ultra-rare pre-leukemic clones via targeted error-corrected sequencing. Leukemia. 2015; 29(7):1608-11. PMC: 4497921. DOI: 10.1038/leu.2015.17. View

11.

Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M . Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest. 1996; 97(3):769-76. PMC: 507115. DOI: 10.1172/JCI118476. View

12.

Young A, Challen G, Birmann B, Druley T . Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun. 2016; 7:12484. PMC: 4996934. DOI: 10.1038/ncomms12484. View

13.

Sano S, Oshima K, Wang Y, Katanasaka Y, Sano M, Walsh K . CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease. Circ Res. 2018; 123(3):335-341. PMC: 6054544. DOI: 10.1161/CIRCRESAHA.118.313225. View

14.

Jaiswal S, Libby P . Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol. 2019; 17(3):137-144. PMC: 9448847. DOI: 10.1038/s41569-019-0247-5. View

15.

Ikonomidis I, Pavlidis G, Katsimbri P, Andreadou I, Triantafyllidi H, Tsoumani M . Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function. Clin Res Cardiol. 2019; 108(10):1093-1101. DOI: 10.1007/s00392-019-01443-9. View

16.

Evans M, Walsh K . Clonal hematopoiesis, somatic mosaicism, and age-associated disease. Physiol Rev. 2022; 103(1):649-716. PMC: 9639777. DOI: 10.1152/physrev.00004.2022. View

17.

Fidler T, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T . The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature. 2021; 592(7853):296-301. PMC: 8038646. DOI: 10.1038/s41586-021-03341-5. View

18.

Jaiswal S, Natarajan P, Silver A, Gibson C, Bick A, Shvartz E . Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017; 377(2):111-121. PMC: 6717509. DOI: 10.1056/NEJMoa1701719. View

19.

Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M . Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. J Am Coll Cardiol. 2018; 71(8):875-886. PMC: 5828038. DOI: 10.1016/j.jacc.2017.12.037. View

20.

Akhiyat N, Lasho T, Ganji M, Toya T, Shi C, Chen X . Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2023; 43(5):774-783. PMC: 10133092. DOI: 10.1161/ATVBAHA.122.318928. View